Products

What will AGI do for Benzylsulfamide?

This classification denotes a topical anti-infective agent with the molecular formula C13H14N2O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AI9WDT80FQ, chemically known as sulfanilamide, n(sup 4)-benzyl- but more generally known as benzylsulfamide, which bears US NIH Compound Identifier 66909. European Medicines Agency schedules Benzylsulfamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05773MIG. The term BENZYLSULFAMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 16, No. 3 1962, List 4). BENZYLSULFAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S(=O)(=O)(NCC1CCCCC1)C1CCC(N)CC1.

How AGI delivers it

Four ways AGI delivers for Benzylsulfamide

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Benzylsulfamide, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Benzylsulfamide, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Benzylsulfamide connects

measured by

  • Assay Puritymodel
  • Impurity Profilemodel
  • Loss On Dryingmodel
  • Melting Pointmodel